Search research articles
Contact Us
Filters
Showing results (1-10 of 35) with videos related to
Page
of 4
Sort By:
Expert Opinion on Investigational Drugs
|
July 5, 2005
Chemokine receptor antagonists: novel therapeutics for inflammation and AIDS
P D Ponath
Expert Opinion on Investigational Drugs
|
November 4, 2000
CCR3 blockade as a new therapy for asthma
C P Bertrand, P D Ponath
Methods in Molecular Biology (Clifton, N.J.)
|
June 7, 2000
Transwell chemotaxis
P D Ponath, J Wang, H Heath
Methods in Molecular Biology (Clifton, N.J.)
|
June 7, 2000
Monoclonal antibodies to chemokine receptors
P D Ponath, N Kassam, S Qin
Immunogenetics
|
January 1, 1989
Structural and evolutionary comparisons of four alleles of the mouse immunoglobulin kappa chain gene, Igk-VSer
P D Ponath, D M Hillis, P D Gottlieb
Human Immunology
|
November 1, 1992
Interferon-gamma response region in the promoter of the class II MHC gene, DPA
M Sugawara, P D Ponath, Z Yang, et al.
Molecular and Cellular Biology
|
December 1, 1994
A factor that regulates the class II major histocompatibility complex gene DPA is a member of a subfamily of zinc finger proteins that includes a Drosophila developmental control protein
M Sugawara, T Scholl, P D Ponath, et al.
The Journal of Clinical Investigation
|
June 13, 1998
The C-C chemokine receptor CCR3 participates in stimulation of eosinophil arrest on inflammatory endothelium in shear flow
J Kitayama, C R Mackay, P D Ponath, et al.
The Journal of Biological Chemistry
|
August 1, 1998
The N-terminal extracellular segments of the chemokine receptors CCR1 and CCR3 are determinants for MIP-1alpha and eotaxin binding, respectively, but a second domain is essential for efficient receptor activation
J E Pease, J Wang, P D Ponath, et al.
Proceedings of the National Academy of Sciences of the United States of America
|
November 15, 1991
Delineation of a previously unrecognized cis-acting element required for HLA class II gene expression
M Sugawara, P D Ponath, J Shin, et al.
Page
of 4
Search research articles
Search
Showing results (1-10 of 35) with videos related to
Sort By:
Page
of 4
Expert Opinion on Investigational Drugs
|
July 5, 2005
Chemokine receptor antagonists: novel therapeutics for inflammation and AIDS
P D Ponath
Expert Opinion on Investigational Drugs
|
November 4, 2000
CCR3 blockade as a new therapy for asthma
C P Bertrand, P D Ponath
Methods in Molecular Biology (Clifton, N.J.)
|
June 7, 2000
Transwell chemotaxis
P D Ponath, J Wang, H Heath
Methods in Molecular Biology (Clifton, N.J.)
|
June 7, 2000
Monoclonal antibodies to chemokine receptors
P D Ponath, N Kassam, S Qin
Immunogenetics
|
January 1, 1989
Structural and evolutionary comparisons of four alleles of the mouse immunoglobulin kappa chain gene, Igk-VSer
P D Ponath, D M Hillis, P D Gottlieb
Human Immunology
|
November 1, 1992
Interferon-gamma response region in the promoter of the class II MHC gene, DPA
M Sugawara, P D Ponath, Z Yang, et al.
Molecular and Cellular Biology
|
December 1, 1994
A factor that regulates the class II major histocompatibility complex gene DPA is a member of a subfamily of zinc finger proteins that includes a Drosophila developmental control protein
M Sugawara, T Scholl, P D Ponath, et al.
The Journal of Clinical Investigation
|
June 13, 1998
The C-C chemokine receptor CCR3 participates in stimulation of eosinophil arrest on inflammatory endothelium in shear flow
J Kitayama, C R Mackay, P D Ponath, et al.
The Journal of Biological Chemistry
|
August 1, 1998
The N-terminal extracellular segments of the chemokine receptors CCR1 and CCR3 are determinants for MIP-1alpha and eotaxin binding, respectively, but a second domain is essential for efficient receptor activation
J E Pease, J Wang, P D Ponath, et al.
Proceedings of the National Academy of Sciences of the United States of America
|
November 15, 1991
Delineation of a previously unrecognized cis-acting element required for HLA class II gene expression
M Sugawara, P D Ponath, J Shin, et al.
Page
of 4